
Cameco Corp's stock jumped 5% in the last session, fueled by renewed optimism in the nuclear sector. Analysts are positive about the company's future as global demand for uranium rises.
In yesterday's trading, Cameco Corp (CCO.TO) saw a notable 5% increase, reflecting strong sentiment in the uranium market. This uptick comes as the company prepares to report its earnings on May 5, with expectations of a significant year-over-year improvement in earnings per share.
Advertisement

Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Cameco Corp
CCO.TO
CCO.TO
Cameco Corp
Market cap
$56.13B
P/E
86.5x
52W high
$182.72
52W low
$95.41
1W change
-4.89%
Beta
1.00
Analyst Price Targets
Based on analyst covering CCO
Wall Street analysts forecast CCO stock price to rise 40.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$179.39
+40.5% Upside
Current Price
C$127.69
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CCO's historical volatility
30-Day Vol
52.9%
Annualized
90-Day Vol
51.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$106.81
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$120.31 | C$100.23 โ C$144.41 |
| 60 trading days | C$113.36 | C$87.56 โ C$146.76 |
| 90 trading days | C$106.81 | C$77.85 โ C$146.54 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Short-term momentum looks positive for Cameco as nuclear energy gains traction globally, but long-term investors should consider valuation metrics carefully.
Cameco's Earnings Estimate: A 163% Year-Over-Year Increase
Cameco is expected to report earnings of 29 cents per share, a substantial increase from last year's results. This anticipated growth shows the company's ability to take advantage of rising uranium prices and increased demand for nuclear energy, positioning it well ahead of its earnings announcement.
Bull case
Strong demand for nuclear energy:
- Global shifts towards nuclear energy are boosting uranium prices.
- Cameco's partnership with Westinghouse strengthens its market position.
- Analysts expect earnings growth, with a consensus estimate of 29 cents per share for the upcoming report.
Bear case
High valuation concerns:
- With a P/E ratio of 123.69x, the stock may be overvalued compared to historical averages.
- Potential volatility in uranium prices could affect earnings unpredictably.
- Recent analyst downgrades may indicate caution among investors.
Why Nuclear Energy is Gaining Traction
The renewed interest in nuclear energy is mainly due to its potential as a stable, low-carbon energy source. Countries are increasingly looking to diversify their energy portfolios, especially with geopolitical tensions affecting traditional energy supplies. This shift is expected to boost demand for uranium, benefiting companies like Cameco.
Cameco's Strategic Position in the Market
Cameco's recent acquisition of a 49% stake in Westinghouse Electric Company positions it uniquely within the nuclear supply chain. This integration allows Cameco to benefit from every stage of the nuclear fuel cycle, strengthening its market presence and creating a mutually beneficial relationship between uranium supply and reactor technology.
Upcoming Earnings: What to Watch For
As Cameco prepares to release its earnings report on May 5, investors should focus on key metrics like earnings per share and any updates on uranium contracts. The market will be eager to see how well Cameco has navigated the recent fluctuations in uranium prices and whether its strategic initiatives are translating into real financial results.
Advertisement


